Patent 7709211 was granted and assigned to University of Medicine and Dentistry of New Jersey on May, 2010 by the United States Patent and Trademark Office.
The invention provides polypeptides encoded by open reading frames present in the genome of Mycobacterium tuberculosis but absent from the genome of BCG and diagnostic and prophylactic methodologies using these polypeptides.